Daniel D Von Hoff, M.D., F.A.C.P.
Physician in Chief and Director of Translational Research at TGen. Chief Scientific Officer for US Oncology and for HonorHealth Clinical Research Institute. Clinical Professor of Medicine, University of Arizona. Serves… Read More
David Sidransky, M.D.
Director of the Head and Neck Cancer Research at Johns Hopkins School of Medicine and Professor of Oncology, Otolaryngology, Cellular & Molecular Medicine, Urology, Genetics, and Pathology at John Hopkins… Read More
Elliot Fishman, M.D.
Director of Diagnostic Imaging and Body Computed Tomography (CT) in the Russell H. Morgan Department of Radiology and Radiological Science, and Professor of Radiology, Surgery, Oncology and Urology at Johns… Read More
Antonio Tito Fojo, MD
Dr. Fojo is currently a professor of medicine at Columbia University Irving Medical Center and the co-director of the Columbia Adrenal Surgery Center. Known for his research toward reversing cancer… Read More
Bruce D. Cheson, M.D., F.A.C.P., F.A.A.S.
Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital. Chairs the Lymphoma Committee of the Cancer and Leukemia Group B and the AJCC Subcommittee… Read More
Manuel Hidalgo, M.D., PhD.
Recently appointed Director of Leon V. & Marilyn L. Rosenberg Clinical Cancer Center and Chief of the Division of Hematology-Oncology at Beth Israel Deaconess Medical Center (BIDMC). Currently Head of… Read More
Axel Hanauske, M.D., Ph.D., MBA
Over 30 years’ experience in oncology drug development, competitive positioning, and translational research at the global level. Hands-on experience with targeted therapeutics, monoclonal antibodies, bispecifics and other novel molecules. Discovered… Read More
Steven Patrick Rowe, M.D., Ph.D.
Associate Professor of Radiology and Radiological Science in the Department of Medicine and Associate Professor of Urology at Johns Hopkins University. Completed residencies in nuclear medicine and radiology at Johns… Read More
Additionally, we are pleased to have a panel of world-renowned Key Opinion Leaders (KOLs) that assist with the design and implementation of imaging in clinical trials.
These KOLs include:
Sunil Sharma M.D. Professor and division director of Applied Cancer Research and Drug Discovery at TGen, Chief of Oncology Research and Drug Discovery at HonorHealth, and formerly of the Huntsman Cancer Institute.
Haesun Choi M.D. Clinical Professor at MD Anderson and developer of the Choi criteria.
Michael Gordon M.D. Oncologist at HonorHealth with expertise in anti-vascular, immunotherapy drug development.
Benjamin Ellingson, PhD. Author of the modified RANO criteria designed to better address pseudo-progression.
Richard Sparks, PhD., DVM, MA, MBA, MS President and Senior Scientist, CDE Dosimetry Services and former image quantification and internal dosimetry consultant to the FDA.
Jonathan Nye, PhD. Assistant Professor and Program Director for PET Research at the Center for Systems Imaging, Emory University School of Medicine.
